HOLOGIC Aktie

 

The latest trading day saw Hologic (HOLX) settling at $63.26, representing a -2.1% change from its previous close....

Hologic is scheduled to report its third-quarter results later this month, and analysts are projecting a marginal decline in profits....

HOLX's GYN Surgical arm gains momentum with Fluent Pro, global expansion and strategic acquisitions fueling growth....

In the latest trading session, Hologic (HOLX) closed at $65.85, marking a +1.46% move from the previous day....

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

Latest Ratings for HOLX DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsEqual-Weight Feb 2022Wells FargoMaintainsOverweight Feb 2022Raymond JamesMaintainsOutperform View More Analyst Ratings for HOLX View the Latest Analyst Ratings read more...

HOLX trades below peers on P/S, but falling EPS, weak Breast Health sales and China risks cloud the outlook....

MARLBOROUGH, Mass.--(BUSINESS WIRE)--$HOLX #earnings--Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the third quarter of fiscal 2025 on Wednesday, July 30, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time. Interested participants may listen to the call by dialing (866) 400-0049 (in the United States and Canada) or +1 (313) 209-4906 (for international callers) and referencing access code 5212316. Participants may also click here to join. Participants should dial in 5-10 minutes before the call begins. Hologic will provide a live and webcast replay of the call on the Company's website at investors.hologic.com. The call will be available there for 30 days. The webcast replay will be available approximately two hours after the call ends. About Hologic Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being...

In the most recent trading session, Hologic (HOLX) closed at $65.11, indicating a +1.31% shift from the previous trading day....

Backed by robust profitability, HOLX deploys billions into acquisitions and repurchases to boost future earnings....

Hologic has outpaced its healthcare equipment peers over the past year, with analysts maintaining a moderately bullish outlook on the stock's future performance....

Hologic (HOLX) concluded the recent trading session at $64.14, signifying a -1.6% move from its prior day's close....

HOLX lifts margins despite tariffs and weak China sales, leaning on diagnostics strength and high-margin buys....

HOLX grapples with global headwinds, but growth in Diagnostics and Breast Health service lifts confidence....

HOLX up 13% over the last month, supported by a rejected $16.7 billion buyout offer and new BCI data. What's the investment outlook?...

HOLX weathers Breast Health softness with rising service revenues, the Endomag acquisition and new tech on the horizon....

Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock....

Latest Ratings for HOLX DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsEqual-Weight Feb 2022Wells FargoMaintainsOverweight Feb 2022Raymond JamesMaintainsOutperform View More Analyst Ratings for HOLX View the Latest Analyst Ratings read more...

Um den gesamten Artikel unter onvista.de zu lesen, klicken Sie bitte auf die Überschrift...

Gesundheit - Der Medizingerätehersteller Hologic hat ein Übernahme-Angebot in Höhe von bis zu 16,7 Milliarden Dollar abgelehnt....